Controlling weight and cardiovascular risk factors is paramount in type 2 diabetes management; however, the definition and ...

Originally designed as glucose-lowering medications, SGLT2 inhibitors provide benefits across the cardio-renal-metabolic ...

Anionic redox is an effective way to increase the capacity of the cathode materials. Na2Mn3O7 [Na4/7[Mn6/7 1/7]O2, for the transition metal (TM) vacancies] with native and ordered TM vacancies can ...

• For BSX BSX, we notice a put option trade that happens to be bullish, expiring in 371 day(s) on June 18, 2026.This event was a transfer of 1500 contract(s) at a $100.00 strike. The total cost ...

Limited evidence exists to support the simultaneous initiation of sodium–glucose cotransporter-2 inhibitors and finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in persons with ...

Participants were randomized in a 1:1:1 ratio to receive empagliflozin 10 mg once daily + placebo, ... Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D. Dec 30, 2023.

Objective To assess the efficacy and safety of the sodium-glucose cotransporter 2 inhibitor dapagliflozin in participants with metabolic dysfunction-associated steatohepatitis (MASH). Design ...

AstraZeneca’s Forxiga recommended by NICE for wider chronic kidney disease use. An estimated 7.2 million people in the UK are living with the progressive condition. AstraZeneca (AZ) has announced that ...

AstraZeneca welcomed NICE’s decision, which expands access beyond previous eligibility criteria set in 2022. It aligns with a recent acceptance by the Scottish Medicines Consortium (SMC) for the same ...

NT-proBNP was elevated at 1,140 pg/ml. EMG indicated myogenic electrophysiological damage. Genetic testing revealed that he carried the familial DES c.1024A>G (p.Asn342Asp) variant. The patient was ...

On ASCO Day 3, AstraZeneca is dominant (again), ... 2-10 Users. $300. Annually per user. $300/year Get Started. $300 Annually per user. View All Plans. To read the rest of this story subscribe to ...